Novel drug targets tumor growth in advanced kidney cancer
Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.
Richard Saltus
• harvard
Feb. 12, 2020 • ~4 min
Feb. 12, 2020 • ~4 min
/
1